ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Watchlist
Price: 21.98 USD 2.4% Market Closed
Market Cap: 3.7B USD

Intrinsic Value

The intrinsic value of one ACAD stock under the Base Case scenario is 19.66 USD. Compared to the current market price of 21.98 USD, ACADIA Pharmaceuticals Inc is Overvalued by 11%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ACAD Intrinsic Value
19.66 USD
Overvaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
ACADIA Pharmaceuticals Inc

Valuation History Unavailable

Historical valuation for ACAD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ACAD?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about ACADIA Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
ACADIA Pharmaceuticals Inc

Current Assets 871m
Receivables 114m
Other Current Assets 757m
Non-Current Assets 261m
PP&E 54m
Intangibles 117m
Other Non-Current Assets 90m
Efficiency

Free Cash Flow Analysis
ACADIA Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ACADIA Pharmaceuticals Inc

Revenue
996m USD
Cost of Revenue
-79m USD
Gross Profit
917m USD
Operating Expenses
-682m USD
Operating Income
235m USD
Other Expenses
-6m USD
Net Income
229m USD
Fundamental Scores

ACAD Profitability Score
Profitability Due Diligence

ACADIA Pharmaceuticals Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional ROE
ROE is Increasing
43/100
Profitability
Score

ACADIA Pharmaceuticals Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

ACAD Solvency Score
Solvency Due Diligence

ACADIA Pharmaceuticals Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Long-Term Solvency
Short-Term Solvency
72/100
Solvency
Score

ACADIA Pharmaceuticals Inc's solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACAD Price Targets Summary
ACADIA Pharmaceuticals Inc

Wall Street analysts forecast ACAD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACAD is 27.26 USD with a low forecast of 15.15 USD and a high forecast of 38.85 USD.

Lowest
Price Target
15.15 USD
31% Downside
Average
Price Target
27.26 USD
24% Upside
Highest
Price Target
38.85 USD
77% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ACADIA Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ACAD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ACAD Insider Trading
Buy and sell transactions by insiders

ACAD News

Other Videos
What is the Intrinsic Value of one ACAD stock?

The intrinsic value of one ACAD stock under the Base Case scenario is 19.66 USD.

Is ACAD stock undervalued or overvalued?

Compared to the current market price of 21.98 USD, ACADIA Pharmaceuticals Inc is Overvalued by 11%.

Back to Top